There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 1

Therapeutic Response After 10 Months of Treatment With Letrozole and Palbociclib in a Postmenopausal Woman With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Metastatic Breast Cancer and Skin Involvement
Authors: Ivan Bivolarski

See all cited by

Overall survival (OS) results from the phase III MONALEESA-2 trial of postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with endocrine therapy ± ribociclib.

Read this article at

Related collections

Model Reduction of Parametrized Systems 2015

Comments

Comment on this article

Similar content 672

Cited by 1